A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis

Clinical trial NCT00134693 · COMPLETED

Trial details

NCT number: NCT00134693
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2005-06-21
Primary completion: 2006-08-03
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.